Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma

Chinese Journal of Oncology

Volumn 33, Issue 9, 2011, Pages 697-701

  Qu, Feng Lian ^a   Hao, Xue Zhi ^b   Qin, Shu Kui ^b   Liu, Ji Wei ^b   Sui, Guang Jie ^b   Chen, Qiang ^b   Qu, Too ^b   Zhang, He Ping ^b   Sun, Yan ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NONE

Author keywords

Arsenic trioxide injection; Liver neoplasms; Pharmacokinetics; Treatment outcome

Indexed keywords

ARSENIC TRIOXIDE;

ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; PRIMARY TUMOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HALF-LIFE; HUMANS; INJECTIONS; LEUKOPENIA; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; OXIDES; QUALITY OF LIFE; REMISSION INDUCTION; SURVIVAL RATE; VOMITING;

EID: 80155133240     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.09.013     Document Type: Article

References (19)

1. Mervis J. Ancient remedy perform new tricks. Science, 1996, 273:578. (Pubitemid 26262088)
2. 3) in Chinese primary hepatocarcinoma patients. Asian Pac J Cancer Prev, 2011, 12:61-65.
3. Huang SG, Kong BH, Yang RF, et al. Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms. Ai Zheng, 2002, 21:401-404.
4. Monzen H, Griffin RJ, Williams BW, et al. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor. Radiat Med, 2004, 22:205-211. (Pubitemid 39264796)
5. Qin S, Bai Y, Ye S, et al. Phase III study of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX 4) versus doxorubicin as palliative systemic chemotherapy in advanced HCC in Asia pts. J Clin Oncol, 2010, 28(15Suppl) :4008.